| HOME >> MEDICINE >> TECHNOLOGY |
Figure 19: Gastric Cancer Therapeutics Market, the US, Annual Cost of Therapy ($), 2002-2010 51
Figure 20: Gastric Cancer Therapeutics Market, the US, Patient Volume ('000s), 2002-2010 52
Figure 21: Gastric Cancer Therapeutics Market, the US, Treatment Usage Patterns ('000s), 2002-2010 54
Figure 22: Gastric Cancer Therapeutics Market, the US, Market Drivers and Restraints, 2009 56
Figure 23: Gastric Cancer Therapeutics Market, the US, Historical Events Impact on the Market, 2010 58
Figure 24: Gastric Cancer Therapeutics Market, the US, Sales Value ($m), 2010-2020 59
Figure 25: Gastric Cancer Therapeutics Market, the US, Annual Cost of Therapy ($), 2010-2020 60
Figure 26: Gastric Cancer Therapeutics Market, the US, Patient Volume ('000s), 2010-2020 61
Figure 27: Gastric Cancer Therapeutics Market, the US, Treatment Usage Patterns ('000s), 2010-2020 62
Figure 28: Gastric Cancer Therapeutics Market, the US, Future Market Drivers and Restraints, 2010-2020 64
Figure 29: Gastric Cancer Therapeutics Market, the US, Gastric Cancer Drug Sales ($m), 2001-2020 65
Figure 30: Gastric Cancer Therapeutics Market, the UK, Sales Value ($m), 2002-2010 69
Figure 31: Gastric Cancer Therapeutics Market, the UK, Annual Cost of Therapy ($), 2002-2010 71
Figure 32: Gastric Cancer Therapeutics Market, the UK, Patient Volume ('000s), 2002-2010 72
Figure 33: Gastric Cancer Therapeutics Market, the UK, Treatment Usage Patterns ('000s), 2002-2010 73
Figure 34: Gastric Cancer Therapeutics Market, the UK, Market Drivers and Restraints, 2009 75
Figure 35: Gastric Cancer Therapeutics Market, the UK, Historical Events Impact on the Market, 2010 77
Figure 36: Gastric Cancer Therapeutics Market, the UK, Sales Value ($m), 2010-2020 78
Figure 37: Gastric Cancer Therapeutics Market, the UK,
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |